[go: up one dir, main page]

AU2001293900A1 - Combination particles for the treatment of asthma - Google Patents

Combination particles for the treatment of asthma

Info

Publication number
AU2001293900A1
AU2001293900A1 AU2001293900A AU9390001A AU2001293900A1 AU 2001293900 A1 AU2001293900 A1 AU 2001293900A1 AU 2001293900 A AU2001293900 A AU 2001293900A AU 9390001 A AU9390001 A AU 9390001A AU 2001293900 A1 AU2001293900 A1 AU 2001293900A1
Authority
AU
Australia
Prior art keywords
particles
asthma
treatment
combination
inhalation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001293900A
Inventor
Petri Ahonen
David Brown
Esko Kauppinen
Esa Muttonen
Wiwik Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8559252&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001293900(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Oyj filed Critical Orion Oyj
Publication of AU2001293900A1 publication Critical patent/AU2001293900A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Inhalation particles incorporating, in an individual particle, a combination of a betahd 2-agonist and a glucocorticosteroid in a predetermined and constant ratio, a process for the preparation thereof and pharmaceutical compositions comprising the inhalation particles. The particles have a narrow particle size distribution and are preferably in the form of spherical crystalline particles with a rough surface. The particles are particularly useful in the treatment of asthma and other respiratory disorders.
AU2001293900A 2000-10-06 2001-10-05 Combination particles for the treatment of asthma Abandoned AU2001293900A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20002216A FI20002216A0 (en) 2000-10-06 2000-10-06 Combination particles for asthma therapy
FI20002216 2000-10-06
PCT/FI2001/000864 WO2002028378A1 (en) 2000-10-06 2001-10-05 Combination particles for the treatment of asthma

Publications (1)

Publication Number Publication Date
AU2001293900A1 true AU2001293900A1 (en) 2002-04-15

Family

ID=8559252

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001293900A Abandoned AU2001293900A1 (en) 2000-10-06 2001-10-05 Combination particles for the treatment of asthma

Country Status (9)

Country Link
US (1) US7172752B2 (en)
EP (1) EP1322301B1 (en)
JP (1) JP4768212B2 (en)
AT (1) ATE284681T1 (en)
AU (1) AU2001293900A1 (en)
CA (1) CA2424621A1 (en)
DE (1) DE60107863T2 (en)
FI (1) FI20002216A0 (en)
WO (1) WO2002028378A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
FI20002215A0 (en) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Combination Particles
FI20011386A0 (en) * 2001-06-28 2001-06-28 Orion Corp Inhalation particles
BRPI0613034A8 (en) 2005-07-14 2018-01-02 Lipothera Inc injectable formulation for fat tissue accumulation, injectable formulation and method for treating fat accumulation, and method for reducing fat tissue.
EP1906919A4 (en) * 2005-07-15 2012-12-26 Map Pharmaceuticals Inc Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof
GB0610090D0 (en) * 2006-05-20 2006-06-28 Price Robert Particulate drug compositions and their uses
MX2009004198A (en) * 2006-10-17 2009-10-19 Lithera Inc Methods, compositions, and formulations for the treatment of thyroid eye disease.
EP1982709A1 (en) * 2007-04-19 2008-10-22 CHIESI FARMACEUTICI S.p.A. Use of a composition comprising formoterol and beclomethasone dipropionate for the prevention or treatment of an acute condition of asthma
EP2022798A1 (en) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
EP2080508A1 (en) * 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Dry powder formulation comprising an anticholinergic drug
US9132084B2 (en) * 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
GB2477030A (en) * 2010-01-15 2011-07-20 Lithera Inc Lyophilised forms of fluticasone, salmeterol and combinations thereof
TWI495466B (en) * 2010-09-23 2015-08-11 Intech Biopharm Ltd Inhaled combination product for asthma
CN102416179B (en) 2010-09-28 2014-05-07 益得生物科技股份有限公司 Inhaled compound composition for asthma
US10179139B2 (en) 2010-10-12 2019-01-15 Cipla Limited Pharmaceutical composition
GEP201606551B (en) 2010-11-24 2016-10-10 Novamedica Llc Selective, lipophilic, and long-acting beta agonists monotherapeutic formulations tions and methods for cosmetic treatment of adiposity and contour bulging
JOP20120023B1 (en) 2011-02-04 2022-03-14 Novartis Ag Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases
MX2014011576A (en) 2012-04-11 2014-11-21 Cipla Ltd Pharmaceutical composition comprising arformoterol and fluticasone furoate.
AU2014262621B2 (en) * 2013-05-08 2018-03-01 Baylor College Of Medicine STAT6 inhibitors

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3268533D1 (en) * 1981-07-24 1986-02-27 Fisons Plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
FR2624505A1 (en) 1987-12-11 1989-06-16 Rhone Poulenc Chimie STABILIZED ZIRCONIA, PROCESS FOR PREPARING THE SAME AND APPLICATION THEREOF IN CERAMIC COMPOSITIONS
US5096629A (en) 1988-08-29 1992-03-17 501 Nippon Fine Chemical Co., Ltd. Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes
FR2651678B1 (en) 1989-09-08 1992-04-30 Glaxo Group Ltd PHARMACEUTICAL COMPOSITION BASED ON SALMETEROL AND BECLOMETASONE DIPROPIONATE.
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Pharmaceutical compositions comprising salmeterol and fluticasone propionate
US5061682A (en) 1990-01-17 1991-10-29 The Washington Technology Center Ceramic precursor mixture and technique for converting the same to ceramic
SE9302777D0 (en) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
WO1993011773A1 (en) * 1991-12-18 1993-06-24 Aktiebolaget Astra New combination of formoterol and budesonide
GB9606677D0 (en) 1996-03-29 1996-06-05 Glaxo Wellcome Inc Process and device
SE9603669D0 (en) 1996-10-08 1996-10-08 Astra Ab New combination
SE9700135D0 (en) * 1997-01-20 1997-01-20 Astra Ab New formulation
US6051257A (en) * 1997-02-24 2000-04-18 Superior Micropowders, Llc Powder batch of pharmaceutically-active particles and methods for making same
ATE284677T1 (en) * 1997-03-20 2005-01-15 Schering Corp PRODUCTION OF POWDER AGGLOMERATES
GB9903759D0 (en) 1999-02-18 1999-04-14 Novartis Ag Organic compounds
IT1309592B1 (en) * 1999-03-05 2002-01-24 Chiesi Farma Spa VEHICLE PARTICLES MODIFIED FOR USE IN THE PREPARATION OF PHARMACEUTICAL FORMULATIONS IN THE FORM OF POLYMERS FOR INHALATION AND
FI20002217L (en) 1999-12-30 2001-07-01 Orion Yhtymae Oyj Inhalation particles
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0009609D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic compositions
GB0009613D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0009607D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
FI20002215A0 (en) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Combination Particles

Also Published As

Publication number Publication date
JP2004510732A (en) 2004-04-08
CA2424621A1 (en) 2002-04-11
EP1322301A1 (en) 2003-07-02
WO2002028378A1 (en) 2002-04-11
DE60107863D1 (en) 2005-01-20
US7172752B2 (en) 2007-02-06
ATE284681T1 (en) 2005-01-15
DE60107863T2 (en) 2005-12-15
US20040052732A1 (en) 2004-03-18
FI20002216A0 (en) 2000-10-06
JP4768212B2 (en) 2011-09-07
EP1322301B1 (en) 2004-12-15

Similar Documents

Publication Publication Date Title
AU2001293899A1 (en) Ihnalation particles incorporating a combination of two or more active ingredients
AU2001293900A1 (en) Combination particles for the treatment of asthma
CA2447210A1 (en) Delivery of aerosols containing small particles through an inhalation route
EP2286797A3 (en) Dry powder composition comprising co-jet milled particles for pulmonary inhalation
WO2002043702A3 (en) Pharmaceutical compositions for inhalation
EP2292212A3 (en) Method of making particles for use in a pharmaceutical composition
MY129384A (en) "pharmaceutical formulations for dry powder inhalers in the form of hard-pellets"
HUP0104478A2 (en) Milling process for the production of finely milled medicinal substances
CA2349268A1 (en) A process for the preparation of suspensions of drug particles for inhalation delivery
CA2290538A1 (en) Composition comprising finely divided, crystalline particles of budesonide
AU2003258706A1 (en) Powder inhaler
EP3494995A3 (en) Formoterol superfine formulation
GB9606677D0 (en) Process and device
AU2002231360A1 (en) Carbon block water filter
WO2003024396A3 (en) Dry powder medicament formulations
EP2298279A3 (en) Pharmaceutical compositions for inhalation
CA2412561A1 (en) Highly efficient delivery of a large therapeutic mass aerosol
AU3085492A (en) Inhalation powders and method of manufacturing them
MY114665A (en) Use of mometasone furoate for treating airway passage and lung diseases
CA2461517A1 (en) Nicotine formulations comprising cocoa and use thereof
EP0831782A4 (en) Methods and system for processing dispersible fine powders
IL169880A0 (en) Compositions formed of coated particles having active ingredients in the particle and in the coating and methods for the preparation thereof
AU2003215659A1 (en) Graft polyols with a bimodal particle size distribution and method for producing graft polyols of this type, in addition to the use thereof for producing polyurethanes
DE60128902D1 (en) FORMULATIONS FOR USE IN INHALATION DEVICES
WO2000033789A3 (en) Inhalation powders